Overview A Study of E7386 in Participants With Advanced Solid Tumor Including Colorectal Cancer (CRC) Status: Recruiting Trial end date: 2023-03-31 Target enrollment: Participant gender: Summary The primary objective of this study is to assess the safety and tolerability of E7386 in participants with solid tumor including CRC. Phase: Phase 1 Details Lead Sponsor: Eisai Co., Ltd.